YD Bio (NASDAQ:YDES) Hits New 52-Week Low – Here’s Why

YD Bio Limited (NASDAQ:YDES) shares reached a new 52-week low during trading on Wednesday . The stock traded as low as $7.08 and last traded at $7.11, with a volume of 15951 shares trading hands. The stock had previously closed at $7.78.

Analyst Ratings Changes

A number of analysts recently weighed in on YDES shares. Wall Street Zen upgraded YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

YD Bio Stock Performance

The business has a 50-day moving average price of $9.83.

Institutional Investors Weigh In On YD Bio

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its position in YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.